Testosterone treatment of excessively tall boys.

作者: M. Zachmann , A. Ferrandez , G. Mürset , H.E. Gnehm , A. Prader

DOI: 10.1016/S0022-3476(76)80742-1

关键词: PsychosocialTestosteroneSurgeryPhysiologyBone maturationMedicineGrowth velocityDiscontinuationTestosterone treatmentSpermBone age

摘要: Twenty-nine tall boys with a mean height prediction of 198 cm were treated for serious psychosocial reasons high doses long-acting testosterone preparation (500 mg/m 2 /month). Their ages at the start treatment ranged from 9.8 to 16.9 years, and duration was 1.2 years. Bone age assessed according Tanner-Whitehouse II (RUS) method, predictions calculated using age-specific regression equations Tanner colleagues. On basis bone treatment, three groups formed (bone 12.1 14, 14.1 15, >15 years), results separately. In whole series, adult reduced by 5.4 cm; best (8 cm) achieved in youngest group. Under maturation accelerated (1.8 years per year) growth velocity increased (youngest group) or normal (older groups). Testicular volume remained prepubertal young patients decreased older ones. After discontinuation testicular sperm count became again after period 1.5 but few cases recovery slower. It is concluded that may be effectively testosterone, are if started early puberty, suppressing effects on pituitary function fully reversible. Since indication one, should carefully selected, taking into account not only also psychological familial factors.

参考文章(23)
Edward L. Rongone, Albert Segaloff, Isolation of Urinary Metabolites of 17α-Methyltestosterone Journal of Biological Chemistry. ,vol. 237, pp. 1066- 1067 ,(1962) , 10.1016/S0021-9258(18)60285-6
Paul M. Hyde, William H. Elliott, E.A. Doisy, Edward A. Doisy, Synthesis and metabolic studies of 17-methyl-C14-testosterone. Journal of Biological Chemistry. ,vol. 208, pp. 521- 528 ,(1954) , 10.1016/S0021-9258(18)65578-4
J M Tanner, R H Whitehouse, W A Marshall, B S Carter, Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Archives of Disease in Childhood. ,vol. 50, pp. 14- 26 ,(1975) , 10.1136/ADC.50.1.14
Jay Ziegenfuss, Ralph Carabasi, Androgens and hepatocellular carcinoma. The Lancet. ,vol. 301, pp. 262- 262 ,(1973) , 10.1016/S0140-6736(73)90098-6
G.C. Farrell, D.E. Joshua, R.F. Uren, P.J. Baird, K.W. Perkins, H. Kronenberg, Androgen-induced hepatoma. The Lancet. ,vol. 305, pp. 430- 431 ,(1975) , 10.1016/S0140-6736(75)91494-4
JerryT. Guy, MilesO. Auslander, ANDROGENIC STEROIDS AND HEPATOCELLULAR CARCINOMA The Lancet. ,vol. 301, pp. 148- ,(1973) , 10.1016/S0140-6736(73)90212-2
Asbjørn Aakvaag, Jørgen H. Vogt, Plasma Testosterone Values in Different Forms of Testosterone Treatment European Journal of Endocrinology. ,vol. 60, pp. 537- 542 ,(1969) , 10.1530/ACTA.0.0600537
J. Mauss, G. Börsch, K. Bormacher, E. Richter, G. Leyendecker, W. Nocke, EFFECT OF LONG-TERM TESTOSTERONE OENANTHATE ADMINISTRATION ON MALE REPRODUCTIVE FUNCTION: CLINICAL EVALUATION, SERUM FSH, LH, TESTOSTERONE, AND SEMINAL FLUID ANALYSES IN NORMAL MEN European Journal of Endocrinology. ,vol. 78, pp. 373- 384 ,(1975) , 10.1530/ACTA.0.0780373
Monte S. Bernstein, Robert L. Hunter, Stanley Yachnin, Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia The New England Journal of Medicine. ,vol. 284, pp. 1135- 1136 ,(1971) , 10.1056/NEJM197105202842006